Stockholm – September 19, 2026 -- Swedish Orphan Biovitrum AB (Sobi) has paid Innate Pharma SA USD 75 million as their strategic oncology partnership becomes legally effective, following the expiration of antitrust waiting periods and satisfaction of other closing conditions.

Santa Ana, Calif. – September 19, 2026 -- Robinson Pharma, Inc. (RPI) has received the "Above and Beyond" Supplier Award from Bausch + Lomb for September 2026, recognizing sustained operational performance following a $115 million infrastructure expansion.

Franklin, Tennessee – September 19, 2026 -- Adora Life Science has appointed Dr. Clinton D. Morgan, MD, as its full-time Chief Medical Officer, effective November 1, 2026, the company announced.

Québec City – September 19, 2026 -- Linearis Labs has secured funding for two projects under the Terry Fox Research Institute's (TFRI) Digital Health Innovation Fund, part of a combined $40.9 million investment spread across 14 pan-Canadian project teams and 55 partners.

New York – September 19, 2026 -- Medisights, an AI-native platform for life sciences, has completed a study showing purpose-built AI agents can compress months of qualitative physician research into days while tracking the fast-shifting multiple myeloma treatment landscape.

Jupiter, Florida – September 19, 2026 -- Myosin Therapeutics, Inc. has been selected as one of just 30 companies for the National Cancer Institute's 2026–2027 Investor Initiatives Showcase, a distinction drawn from NCI's full portfolio of funded companies following a competitive review by more than 70 third-party investors and strategic partners.

Exton, Pa. – September 18, 2026 -- Kibow Biotech's redesigned website, KibowBiotech.com, has been named Best Science Website in the 2026 WebAward Competition, run by the Web Marketing Association across seven judging criteria including design, innovation, content and ease of use.

Hopewell, N.J. – September 18, 2026 -- ProBio, a global contract development and manufacturing organization (CDMO), has struck a strategic collaboration with Kun Tuo, an IQVIA-owned clinical research organization (CRO) in China, to integrate manufacturing and clinical trial execution for advanced therapies.

San Jose, Calif. – September 18, 2026 -- Anixa Biosciences (NASDAQ: ANIX) has appointed Carmen Guerra, M.D., M.S.C.E., F.A.C.P., to its Cancer Business Advisory Board as the company prepares to advance its breast cancer vaccine into a Phase 2 clinical trial and continues its ovarian cancer CAR-T therapy Phase 1 trial.

Atlanta – – September 18, 2026 -- Alzamend Neuro, Inc. (Nasdaq: ALZN) has regained compliance with Nasdaq's minimum stockholders' equity rule, ending a listing threat that began in March 2026.